VNRX - VolitionRX Limited Common Stock -  [ ]

Ticker Details
VolitionRX Limited Common Stock
VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
IPO Date: April 1, 2012
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $5.69M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.10 | 3.90%
Avg Daily Range (30 D): $0.05 | 6.20%
Avg Daily Range (90 D): $0.09 | 5.71%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): .54M
Avg Daily Volume (90 D): .64M
Trade Size
Avg Trade Size (Sh.): 477
Avg Trade Size (Sh.) (30 D): 214
Avg Trade Size (Sh.) (90 D): 224
Institutional Trades
Total Institutional Trades: 12
Avg Institutional Trade: $2.06M
Avg Institutional Trade (30 D): $.68M
Avg Institutional Trade (90 D): $.68M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.26M
Avg Closing Trade (30 D): $.68M
Avg Closing Trade (90 D): $.68M
Avg Closing Volume: 49.24K
 
News
May 27, 2026 @ 12:17 PM
VolitionRx Highlights Commercial Momentum and Mult...
Source: Prnewswire
Jan 3, 2024 @ 12:59 PM
Why Trinity Place Holdings Shares Are Trading High...
Source: Avi Kapoor
Nov 27, 2023 @ 11:26 AM
IO Biotech And 2 Other Stocks Under $2 Insiders Ar...
Source: Lisa Levin
Nov 20, 2023 @ 1:45 PM
Ondas Holdings And 2 Other Stocks Under $1 Insider...
Source: Lisa Levin
Oct 6, 2023 @ 12:26 PM
Top 4 Health Care Stocks That Are Preparing To Pum...
Source: Lisa Levin
Financials
  TTM Q1 2026 Q4 2025
Basic EPS
Diluted EPS $-.85 $-.97
Revenue $.4M $.99M $.45M
Gross Profit
Net Income / Loss $-7.32M $-6.7M $-6.3M
Operating Income / Loss $-4.16M $-5.35M $-4.82M
Cost of Revenue
Net Cash Flow $-.31M $1.99M $.92M
PE Ratio    
Splits
Apr 28, 2026 1:20